Category: Corona Virus Vaccine

Page 240«..1020..239240241242..250260..»

Pfizer says it has second doses of COVID-19 shot on hand, expects no U.S. supply problems – Reuters

January 18, 2021

FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo

(Reuters) - Pfizer Inc has been holding on to second doses for each of its COVID-19 vaccinations at the request of the federal government and anticipates no problems supplying them to Americans, a spokeswoman said in a statement on Friday.

Pfizers comments run counter to a report in the Washington Post that the federal government ran down its vaccine reserve in late December and has no remaining reserves of doses on hand.

Operation Warp Speed has asked us to start shipping second doses only recently, the spokeswoman said. As a result, we have on hand all the second doses of the previous shipments to the US.

The U.S. Department of Health and Human Services did not respond to requests for comment.

Pfizer has shipped more than 15 million doses to destinations around the United States, primarily from its Michigan facility, and expects to be able to produce around 2 billion doses worldwide in 2021, the spokeswoman said.

The United States has been struggling to administer the shots that have been distributed, however. Only around 12 million of the more than 31 million doses that have been shipped have been administered, according to data from the U.S. Centers from Disease Control and Prevention.

Scattered vaccine shortages were reported on the front lines of the U.S. battle against the coronavirus pandemic on Friday, prompting at least one large healthcare system to cancel a slew of appointments of people hoping to be inoculated.

Earlier on Friday, Pfizer announced there would be a temporary impact on shipments to European countries in late January to early February caused by changes to manufacturing processes to boost output. [L1N2JQ0V3]

Around nine of the 27 governments in the European Union complained of insufficient doses at a meeting this week, a participant said.

Reporting by Carl ODonnell; Editing by Leslie Adler and Sonya Hepinstall

Read the original:

Pfizer says it has second doses of COVID-19 shot on hand, expects no U.S. supply problems - Reuters

COVID-19 vaccine roll out: Over 400 cases of adverse events reported in 2 days – Mint

January 18, 2021

Over 400 cases of adverse event following immunisation were reported in two days after India had commenced the "world's largest vaccination drive" on 16 January, the health ministry said on Sunday. Around 2.24 lakh healthcare and frontline workers were inoculated in the first two days of the inoculation drive.

"447 cases of AEFI (Adverse event following immunization) reported on 16th and 17th January, only three required hospitalisation," the health ministry stated on Saturday. Any untoward medical occurrence which follows immunisation and does not necessarily have a causal relationship with the usage of the vaccine, is known as AEFI, according to World Health Organisation (WHO).

Of these, one has been discharged from Northern Railway Hospital Delhi within 24 hours; one has been discharged from All India Institute of Medical Sciences (AIIMS) Delhi; and one is under observation in AIIMS Rishikesh and is being monitored," said Manohar Agnani, additional secretary, ministry of health and family welfare.

Protocols are in place for reporting, immediate case management at vaccination session site, transportation and hospitalization and further care of such cases. Protocols are also in place for systematic investigation and causality assessment of serious AEFIs," he said.

A worker in All India Institute Of Medical Science (AIIMS) was admitted to a hospital as he developed an allergic reaction after getting Covaxin shot on Saturday.

"An All India Institute of Medical Sciences, Delhi security guard has developed an allergic reaction after receiving COVID-19 vaccination here on Saturday. He is kept under observation of doctors at the hospital," an AIIMS official said.

He was discharged later.

At least 17,072 beneficiaries received COVID-19 vaccine on the second day of nationwide inoculation drive. A total of 553 sessions were held in six States Andhra Pradesh (308), Arunachal Pradesh (14), Karnataka (64), Kerala (1), Manipur (1) and Tamil Nadu (165).

India has vaccinated the highest number of persons on first day under its COVID-19 vaccination program, the worlds largest such exercise. This is much higher than many other countries such as USA, the UK and France. Total of 2,24,301 beneficiaries have been vaccinated till today as per the provisional report," said Agnani.

States/UTs have been advised to plan covid-19 vaccination sessions four days in a week to minimize disruption of the Routine Health Services. Some states have already publicized their weekly vaccination days," said Agnani.

The union health ministry also had a meeting with all states on Sunday to review the progress of the vaccination drive.

Subscribe to Mint Newsletters

* Enter a valid email

* Thank you for subscribing to our newsletter.

See original here:

COVID-19 vaccine roll out: Over 400 cases of adverse events reported in 2 days - Mint

Virginia Department of Health gives update on COVID-19 vaccine – WAVY.com

January 18, 2021

Posted: Jan 16, 2021 / 11:41 PM EST / Updated: Jan 16, 2021 / 11:41 PM EST

HAMPTON ROADS, Va. (WAVY) There have been some frustrations with the rate of vaccinations across Virginia.

Saturday, the Virginia Department of Health (VDH) gave an update on the states plan to distribute the COVID-19 vaccine.

As of Saturday, VDH is reporting that its health officials have administered 295,202 doses.

That is out of the total number of vaccines distributed throughout Virginia of 943,400.

They have been steadily increasing the number of doses a day and health department leaders believe they are moving in the right direction.

There are still a lot of questions.

There is a gap there and I think its led a lot of people to ask questions like what is going on? Are doses sitting on shelves? How are we not getting doses to people who need it?' questioned Dr. Danny Avula.

Leaders said much of that is in part due to the distributors and making sure the vaccine is getting to the right channels.

Primarily through hospitals, through health departments, through private providers, through pharmacies, and then also through the long-term care facilities, said Avula.

As we move forward into phase 1b, we know people like first responders, childcare workers, and food service workers will be included but the Commonwealth has taken the suggestion to add another group to the 1b category.

As a Commonwealth, we decided to follow the federal governments lead andadd those 65 and up and those with underlying conditions to our phase 1b, Avula continued.

They are now getting more than 100,000 doses a week andmuch of the state is looking for the second dose shipment.

This vaccine is a two-dose vaccine and the way the federal government has been out allocating that, theyve been sending out doses and holding back second doses. Then, delivering the second doses to different providers as they came up ready to do that round of second doses. So, we are hearing very consistent messaging that all of those doses will be released, he said.

Overall, the future of the vaccine in the state is relies on one thing.

Our future allocations, our ability to get more vaccines in Virginia is really going to be dependent on having clear and accurate data, and knowing how much, exactly, the vaccine has been used, he said.

State leaders say they expect more shipments to come sometime in March.

Visit link:

Virginia Department of Health gives update on COVID-19 vaccine - WAVY.com

Australians stranded overseas share their experiences getting the COVID-19 vaccine – ABC News

January 18, 2021

When nurse Chiara Gelli moved from Queensland to the UK with her partner in December 2019, she couldn't have known the coronavirus pandemic would turn her life upside down in a matter of months.

"My initial plan was to travel around and work here and there, just picking up shifts," the 25-year-old told the ABC.

"When we first moved here, the pandemic barely even started. We had no idea it was going to be what it is.

"It just flipped my whole year on its head. All the plans we had just got pretty much thrown out the window."

The UK soon became an epicentre of coronavirus in Europe; more than 80,000 people have died in Britain, the fifth-highest official death toll in the world, and it's estimated one in 50 people have been infected with the virus.

But Ms Gelli didn't hesitate to put her hand up to join an emergency department in the north-east of England to fight the virus.

"[It] is a really amazing thing to be a part of, even though it's incredibly hard. You learn so much from it," she said.

"It makes a really strong bond between you and your workmates."

The UK has since become the first country to approve vaccines developed by Pfizer and BioNTech.

As a frontline worker, Ms Gelli was among the first wave of people to receive the Pfizer injection.

She said it was normal for many health workers to be vaccinated at her hospital and it was a smooth process.

"[The nurse] had to handle the vaccine in a very delicate manner, they're not allowed to handle the vaccine with sudden movements, shaking or tapping," Ms Gelli said.

"But the whole process was easy. It was literally just like getting any other vaccine.

"I didn't feel sick or anything, I went to work the next day on Christmas."

Governments around the world are scrambling to vaccinate their citizens, following the emergence of highly transmittable mutant strains of COVID-19 that have posed new challenges.

The British Government has recently been under fire for delaying second doses of the Pfizer vaccine, saying it wanted to give as many people as possible just the first shot now, citing a supply issue.

As the UK rolls out Pfizer's COVID-19 vaccine, the next stage of its vaccine research begins.

Ms Gelli said she was due for her second shot last week, but she recently received an email from the National Health Service (NHS) saying the window had been extended to up to 12 weeks under the latest national guidance.

"The Joint Committee on Vaccination and Immunisation (JCVI) is confident 12 weeks is a reasonable dosing interval to achieve good longer-term protection," the email read.

"At the start it concerned me," Ms Gelli said.

"They reckon it is acceptable to have the second dose within the 12-week time frame since having the first dose.

"Don't know how true that is, but we will see."

This month, BioNTech and partner Pfizer said "there is no data to demonstrate that protection after the first dose is sustained after 21 days", according to Reuters.

Despite that, Ms Gelli said she was grateful to be part of the vaccination program.

"It was a bit of a Christmas present," she said.

"I think they're still finding some more stuff out as we go through it, but I'm happy to be the guinea pig to be honest."

So far, Britain has given some 2 million people a COVID-19 vaccination and is aiming to vaccinate about 14 million people by mid-February.

Across the pond, Alison Kirkpatrick, an occupational therapist at a trauma hospital in Dallas, Texas, is now fully vaccinated.

She said her hospital was the first in North Dallas to receive the Pfizer vaccine and 75 per cent of the employees were now vaccinated.

Ms Kirkpatrick, who is a dual US-Australian citizen, said she was warned about some minimal side effects when it came to the second dose.

"There may be things like fatigue, muscle aches, soreness, a fever, and things like that," she said.

"I was a little bit more worried for the second jab, but honestly, I didn't have any reactions at all to either of them."

Although there are some reports of people having severe allergic reactions afterwards, that didn't deter her.

She sought peace of mind by educating herself.

"I had done a lot of research before I volunteered to receive it," Ms Kirkpatrick said.

"I've read up a lot about the theory of the messenger RNA (mRNA), and the process of how the vaccine was supposed to work, because a lot of people are scared of a new vaccine."

One's slow, one's never worked and the other could 'go rogue' inside you: three options for a coronavirus vaccine to free the world.

The US has been hit hard by the pandemic, with more than 4,000 deaths recorded within just 24 hours a week ago.

For Ms Kirkpatrick, being a health worker meant having close to no social life at all, along with countless periods of self-isolation to protect others from potential COVID-19 exposure.

"All the people that I work with were very protective, we stay in a very small circle," she said.

"We have probably socially isolated more than anybody else in the country because of the type of work that we do.

"I run marathons when I'm not working, [but] I've been hesitant to go out and go to a running group or a training group since I've been working in the hospital."

Ms Kirkpatrick said she hoped getting vaccinated would bring her one step closer to a normal life.

"I'm looking forward to just being able to maybe go out and have a meal at a restaurant maybe go to the supermarket when it's not the crack of dawn, and nobody else is there," she said.

While more than 40 countries have begun administering COVID-19 vaccines, Australia is yet to begin its rollout.

Last week, Prime Minister Scott Morrison brought forward the rollout of the Pfizer-BioNTech vaccine to mid-to-late February from March, with a target of inoculating 4 million people by the end of March.

But for some Australians stranded overseas like Richard Anese, that can't come soon enough.

Mr Anese is a former aircrew member who is currently stuck in Abu Dhabi in the United Arab Emirates (UAE).

He volunteered in a trial program for the Chinese vaccine developed by Sinopharm in August last year.

"I just thought when all your decisions are taken away from you it's just so important for yourself to actually be able to make just even one," the 57-year-old originally from Sydney told the ABC.

"I also wanted to contribute my small part to humanity."

The UAE's National Emergency Crisis and Disaster Management Authority said on Monday the country had achieved a vaccine distribution rate of 11.8 doses per 100 people, which is just second behind Israel globally.

Mr Anese said he thought Western countries could learn from the UAE when it came to the vaccine rollout.

"This was due to a nationalised approach, the uptake and the compliance level was incredibly high as a result," he said.

"I think [the vaccination] should have been mandated in the first instance, there shouldn't have been any delay with that [in Australia]."

Others like Ms Kirkpatrick saw the merits of both approaches.

"Here in the US we can't afford the time to wait," she said.

"On the other hand, [Australia] can afford to be hesitant because of the way they've managed it in the first place."

For Ms Gelli, she said she hoped being vaccinated would get her home sooner.

"Naturally, I just want to come home, I'm a big home girl and I'm not one for cold weather," she said.

"My message is don't be scared to get the vaccine at all. I am the living proof that it's perfectly fine."

The ABC asked the Department of Foreign Affairs and Trade (DFAT) whether being vaccinated would speed up the process for Australians looking to return from overseas.

"At this time, vaccination against COVID-19 does not change the mandatory 14-day quarantine for travellers to Australia at designated facilities in the first port of arrival," DFAT said in a statement.

Continue reading here:

Australians stranded overseas share their experiences getting the COVID-19 vaccine - ABC News

Do you qualify for a COVID-19 vaccine in Iowa? Check our chart to find out – The Gazette

January 18, 2021

"When can I get the COVID vaccine?" Many Iowans are asking this question. And while there are seemingly moreunknowns than answers, here's what we know right now.

Look at the chart below to find your age group to seeif you or your loved ones qualify for the coronavirus vaccine in Iowa.

If you are wondering why people under 75 with medical conditions aren't qualified, that's because the state has not yet prioritized that group, unless a person meets other criteria, such as working or living in an at-risk setting(details in the chart below). The state is expected to provide more information soon, onceofficials "have reasonable confidence that supply meets the demands of this broader eligibility criteria."

Read more:Q&A: What we know about Iowa's COVID vaccine plan

This graphic was updated with information available as of Jan. 15, 2021.

Source: Iowa Department of Public Health and local health departments.

What questions do you have about the vaccine?

Do you have questions about the COVID-19 vaccine? Share your questions in the form at this link, and we'll work to find the answers.

The rest is here:

Do you qualify for a COVID-19 vaccine in Iowa? Check our chart to find out - The Gazette

Coronavirus vaccine supply limited as state expands eligibility next week – Crain’s Cleveland Business

January 18, 2021

More than 360,000 people in Ohio have been vaccinated against COVID-19, Gov. Mike DeWine announced Thursday, Jan. 14.

That number represents about 72% of the vaccines the state has received from the federal government.

"We do not have enough vaccines in Ohio right now, but we hope our allotment will increase in the future," he added.

Those 80 years and older will be added to front line health care workers and congregate care staff and residents as Ohioans permitted to receive a COVID-19 vaccine. DeWine warned, however, that with more than 400,000 residents in that age bracket and only 100,000 vaccines available, the supply will be insufficient.

"The big picture on vaccines is that we do not have enough," the governor said.

Those in the eligible demographic must register with one of the state's 750 providers which will be made public by county health departments this week, DeWine said.

Although there is no plan yet for a centralized state site to register to get the vaccine, Ohio plans to post information about the local providers on the health department site starting Friday.

The Ohio Health Department reported 7,654 new COVID-19 cases, 109 fatalities and 340 new hospitalizations, with 37 of those people admitted to an intensive care unit for Thursday. All of those reported indicators are above the 21-day average.

New coronavirus cases statewide have also increased since last week from an average of 657 positive cases per 100,000 population to 740 positive cases per 100,000 population.

"We are not seeing a dramatic surge after Christmas and New Year, but there is a bit of an upswing in cases," DeWine said.

Lt. Jon Husted also announced that General Motors committed to invest $12 million as part of an agreement that includes the company refunding $28 million in tax credits to the state.

General Motors received tax credits for an assembly plant in Lordstown and then shuttered the facility in 2019.

Per the settlement, Youngstown State University will receive $5 million for a workforce development program and funding for the university's Energy Storage Innovation and Training Center. The village of Lordstown is set to receive $3 million for a new water tower. The Eastgate Regional council government will get $2.5 million for infrastructure projects, and $1.5 million will go to support the Mahoning Valley Manufacturers Coalition.

Read more from the original source:

Coronavirus vaccine supply limited as state expands eligibility next week - Crain's Cleveland Business

4 of 6 COVID vaccine megasites in N.J. are open. Heres how to get an appointment. – NJ.com

January 18, 2021

Four of the six coronavirus vaccine mega-sites have opened up throughout New Jersey to serve as vaccinations hubs.

The four locations currently open are the Moorestown Mall in Burlington County, Rowan College of South Jersey in Gloucester County, the New Jersey Convention and Exposition Center in Middlesex County and Rockaway Townsquare in Morris County. Two additional sites will open later in East Rutherford and Atlantic City.

Each site is currently offering the shot only to priority groups, including healthcare professionals, EMS teams, police officers and firefighters, people over age 65, those with chronic health conditions and smokers. State officials have said each location will eventually have the capacity to vaccinate thousands of people per week, but doesnt currently because the federal government is not providing enough doses.

Many vaccine sites throughout the state do not show availability due to supply not meeting demand. State officials have said more appointments will become available as New Jersey receives additional vaccines.

Heres how to get an appointment at each site.

The Moorestown site, which launched on Friday, was chosen due to its proximity to Camden County. Anyone in the region can set up an appointment. However, walk-ins are not allowed.

To schedule an appointment, visit Virtua.org/vaccine and complete the form. You will then receive either a text or email that will contain a link to schedule your appointment.

You should bring a health insurance card if you have one, a federal, state or local identification card and employer-issued identification.

Information on the second-dose appointment will be provided in-person at the initial appointment.

Answers to frequently asked questions about the site can be found here.

The 30,000-square-foot facility in Sewell opened on Jan. 8 and will be able to handle more than 2,000 people a day once vaccines are widely available in New Jersey.

Registration is required to receive the two doses, according to the colleges website. A link to pre-register with the state can be found at RCSJ.edu/vaccine.

Vaccination hours will be 8 a.m. to 6 p.m., 7 days a week.

Those with appointments can enter the campus at 1400 Tanyard Road though either North Campus Drive or West Campus Drive and park in Lot E, then follow cones to the Instructional Center.

The Edison site, located at 97 Sunfield Avenue, is equipped with 20 vaccination stations and will be open weekdays from 8 a.m. until 4 p.m. It opened on Friday.

The Pfizer-BioNTech and Moderna vaccines will be administered at the site, but people registering cannot choose which vaccine they want.

Qualified individuals can complete a vaccine registration form on RWJ BarnabasHealths website here. You will then receive an email or text to schedule an appointment through a link to a scheduling app.

Due to the high volume of requests, you will not get the link immediately, according to the website. You will be entered into a queue to receive the scheduling link based on the number of people who requested a vaccine before you.

The Rockaway site opened Jan. 11 in the shuttered, 30,000 square-foot Sears department store at the Rockaway Townsquare shopping center on Mt. Hope Avenue. The vaccination center is on the lower level of the building.

Reservations must be made using an on-line registration form on Atlantic Health Systems website, found here.

According to their website, there are currently no appointments available, but you can sign up for appointment alerts. Scroll to the bottom of the page to opt in for alerts.

Appointments for second doses will be made on-site when the first dose is administered.

If you are a healthcare worker or work on the front lines and qualify for the vaccine but havent been able to secure an appointment, wed like to hear from you. Tell us your stories on our COVID tip line.

Our journalism needs your support. Please subscribe today to NJ.com.

Avalon Zoppo may be reached at azoppo2@njadvancemedia.com. Follow her on Twitter @AvalonZoppo.

Read more from the original source:

4 of 6 COVID vaccine megasites in N.J. are open. Heres how to get an appointment. - NJ.com

Texas researchers will soon have a COVID-19 vaccine in 190 countries, but not the US – 12newsnow.com KBMT-KJAC

January 16, 2021

A COVID-19 vaccine made partly by Texas scientists with research from a Texas university may soon be ready for global distribution, but it's not allowed in the U.S.

HOUSTON, Texas Inside the halls of Baylor College of Medicine Houston, Dr. Peter Hotez and his team rush tofinalize work they startedin 2011.

We adopted a coronavirus vaccine program about a decade ago because it was in dire straits. Nobody cared about coronavirus, Dr. Hotez, M.D., Ph.D., Dean for the National School of Tropical Medicine Baylor College of Medicine Houston, said.

The program looked to create SARS and MERS vaccines. Dr. Hotez said his team was in a good position to focus on the vaccine for SARS-coV-2, the virus causing COVID-19.

We use a technology that's around 40 years old. The same one used to make the recombinant hepatitis B vaccine, Dr. Hotez said.

The vaccine is in trial in India.

We're not part of Operation Warp Speed because we're not a pharma company ... you have to have financial support, Dr. Hotez said.

The Baylor vaccine is cheaper to make and sell.

The great thing about India is Indias got this tradition of making vaccines for the world. Serum Institute of India in Poona (now Pune) near Mumbai, is the world's largest producer of vaccines ... We think ours could come in as a low-cost global health vaccine for the world, which is going to be important because those mRNA vaccines probably are not going to filter to low- and middle-income countries anytime soon, Dr. Hotez said.

The vaccine must be used globally.

It feels really good to be able to make such a global contribution. At the same time, Im frustrated that we can't bring that back into the U.S. easily because if we can make it, we can make a billion doses. It could solve a lot of problems here in the U.S. as a low-cost vaccine, Dr. Hotez said.

Most of the vaccines will go toCOVAX, a global initiative 190 countries joined but the U.S. decided to not take part.

We'd love to be able to bring it back into the U.S., maybe as a pediatric vaccine for parents who may not be so eager to vaccinate their kids with the new-technology vaccines, Dr. Hotez said.

We're trying to knock on doors and that sort of thing. You would think, right, with all the demand, people wringing their hands, 'Are we going to have enough vaccine?' It wouldn't be so tough. But, you know, because we're not a pharmaceutical company, that kind of thing falls through the cracks in that way, Dr. Hotez said.

More here:

Texas researchers will soon have a COVID-19 vaccine in 190 countries, but not the US - 12newsnow.com KBMT-KJAC

The Red Tape Facing Older People Who Want the Covid-19 Vaccine – The New York Times

January 16, 2021

We have to ensure that the experience, particularly for our elders, including frail elders, is as easy as possible, Dr. Chokshi said.

For now, many older adults are getting help from friends and relatives, but even that is no guarantee of success. In Riverdale, in the Bronx, Annette Gaudino, who works as policy director for a health advocacy organization, had been trying to register her 95-year-old mother for two days, checking multiple locations. She was not sure if she would be allowed to accompany her to the appointment.

My mom is increasingly confused, needs a walker and has a part-time home care aide who also needs vaccination, she said. Theres got to be a better way.

Joan Jeffri, 76, who lives in Midwood, Brooklyn and who was frustrated after being confirmed for an urgent care appointment only to be told later that they had no vaccine sent a letter to Gov. Andrew M. Cuomo alerting him to the problems.

The lightest moment in her last few days, she said, was when she clicked on the link to her local Rite Aid through the citys website, only to be told there were 11,624 people waiting to enter the website in front of her.

I burst out laughing, she said.

Her daughter-in-law finally got her an appointment at a city site after two hours of effort, and she goes for her shot in two weeks.

Everyone I speak to is insanely and completely frustrated, Ms. Jeffri said, and has spent between two and eight hours or more trying to get through.

Sean Piccoli contributed reporting.

Excerpt from:

The Red Tape Facing Older People Who Want the Covid-19 Vaccine - The New York Times

Page 240«..1020..239240241242..250260..»